According to a regulatory filing, on December 20, 2024, the board of directors of DocGo (DCGO) approved an extension of the expiration date of the company’s current share repurchase program from December 31, 2024 to June 30, 2025. As previously disclosed, pursuant to the Repurchase Program, the company may purchase up to $26M in shares of the company’s common stock. Other than the extension of the program’s expiration date, no changes were made to the Repurchase Program. Under the terms of the Repurchase Program, as extended, the company may continue to purchase shares of its common stock on a discretionary basis from time to time through open market repurchases or privately negotiated transactions or through other means, including by entering into Rule 10b5-1 trading plans or accelerated share repurchase programs, in each case, during an “open window” and when the company does not possess material non-public information.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on DCGO:
- DocGo and SHL Telemedicine partner to put 12-lead devices in health care units
- DocGo annouces 2-year transportation contract with Tennessee healthcare system
- DocGo unit Cardiac RMS’s expands to ‘major’ Mississippi hospital system
- DocGo announces new contract for ambulance transport services in North Texas
- 3 Best Stocks to Buy Now, 11/8/2024, According to Top Analysts
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
